Press release
Corporate Press
March 29, 2010

Evonik acquired the business of Methacrylate Specialty Esters from Arkema

Evonik Industries, one of the world’s leading suppliers of methacrylate chemicals, has acquired the business of Methacrylate Specialty Esters from Arkema as of the end of 2009. With this acquisition, Evonik enhances its competence in the business unit Performance Polymers as a specialist in methacrylate chemistry and as a reliable global partner within the chemical industry.

The acquisition concerns the products 2-Ethylhexyl Methacrylate (2-EHMA), Dimethylaminoethyl Methacrylate (MADAME), and n- and i-Butyl Methacrylate (n-BUMA and i-BUMA). These monomers are mainly used for the production of paints and coatings, as well as chemicals for water treatment and plastics additives. The products will be integrated into the VISIOMER® sales range for methacrylate monomers, which comprises of more than 50 monomers. The product VISIOMER® DMAEMA will be marketed under the name VISIOMER MADAME™ in the future.

About Evonik

Evonik Industries is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company’s performance is shaped by creativity, specialization, continuous self-renewal, and reliability.

Evonik is active in over 100 countries around the world. In its fiscal year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.